UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307C952. A total of 5 filers reported holding UNITED THERAPEUTICS CORP DEL in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $677,610 | -86.5% | 3,000 | -86.6% | 0.00% | -88.9% |
| Q1 2023 | $5,016,704 | +17939.9% | 22,400 | +22300.0% | 0.02% | – |
| Q4 2022 | $27,809 | +15.9% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $24,000 | +33.3% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | -92.5% | 100 | -92.3% | 0.00% | – |
| Q3 2021 | $240,000 | +233.3% | 1,300 | +225.0% | 0.00% | – |
| Q2 2021 | $72,000 | +323.5% | 400 | +300.0% | 0.00% | – |
| Q1 2021 | $17,000 | -97.0% | 100 | -98.3% | 0.00% | -100.0% |
| Q1 2020 | $569,000 | +4.2% | 6,000 | -3.2% | 0.01% | +25.0% |
| Q4 2019 | $546,000 | +582.5% | 6,200 | +520.0% | 0.00% | +300.0% |
| Q3 2019 | $80,000 | +29.0% | 1,000 | +25.0% | 0.00% | 0.0% |
| Q2 2019 | $62,000 | +416.7% | 800 | +700.0% | 0.00% | – |
| Q1 2019 | $12,000 | -94.1% | 100 | -93.8% | 0.00% | -100.0% |
| Q3 2018 | $205,000 | +9.0% | 1,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $188,000 | -50.0% | 1,600 | -33.3% | 0.00% | -50.0% |
| Q4 2015 | $376,000 | +19.4% | 2,400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $315,000 | -24.5% | 2,400 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $417,000 | +27.1% | 2,400 | +26.3% | 0.01% | +20.0% |
| Q1 2015 | $328,000 | +33.3% | 1,900 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $246,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 22,400 | $5,016,704 | 0.02% |
| JANE STREET GROUP, LLC | 63,000 | $14,109,480 | 0.01% |
| SIMPLEX TRADING, LLC | 7,400 | $1,657 | 0.00% |
| JPMORGAN CHASE & CO | 19,200 | $4,300,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |